114 related items for PubMed ID: 17003094
1. Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Dötsch J, Rascher W, Dörr HG.
J Clin Endocrinol Metab; 2006 Dec; 91(12):4888-95. PubMed ID: 17003094
[Abstract] [Full Text] [Related]
2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
3. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF, Charmandari E, Dattani MT, Hindmarsh PC.
Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
[Abstract] [Full Text] [Related]
4. Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency?
Völkl TM, Simm D, Körner A, Rascher W, Kiess W, Kratzsch J, Dörr HG.
Eur J Endocrinol; 2009 Feb; 160(2):239-47. PubMed ID: 19004982
[Abstract] [Full Text] [Related]
5. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Körner A, Kiess W, Kratzsch J, Dörr HG.
Acta Paediatr; 2009 May; 98(5):885-91. PubMed ID: 19236311
[Abstract] [Full Text] [Related]
6. 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia--a preliminary report.
de Silva KS, Kanumakala S, Brown JJ, Jones CL, Warne GL.
J Pediatr Endocrinol Metab; 2004 Aug; 17(8):1089-95. PubMed ID: 15379420
[Abstract] [Full Text] [Related]
7. Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.
Bonfig W, Roehl FW, Riedl S, Dörr HG, Bettendorf M, Brämswig J, Schönau E, Riepe F, Hauffa B, Holl RW, Mohnike K, AQUAPE CAH Study Group.
Am J Hypertens; 2016 Feb; 29(2):266-72. PubMed ID: 26071487
[Abstract] [Full Text] [Related]
8. Ambulatory blood pressure and subclinical cardiovascular disease in patients with congenital adrenal hyperplasia: a preliminary report.
Akyürek N, Atabek ME, Eklioğlu BS, Alp H.
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):13-8. PubMed ID: 25800471
[Abstract] [Full Text] [Related]
9. 24-hour blood pressure profiles in children with congenital adrenal hyperplasia on two different hydrocortisone treatment regimens.
Liivak K, Tillmann V.
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):511-7. PubMed ID: 19694198
[Abstract] [Full Text] [Related]
10. Normal ambulatory blood pressure in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.
Borges JH, Camargo DA, Sewaybricker LE, Santoro RI, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra G, Gonçalves EM.
Arch Endocrinol Metab; 2023 Jan 18; 67(1):64-72. PubMed ID: 35929901
[Abstract] [Full Text] [Related]
11. Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.
Ariyawatkul K, Tepmongkol S, Aroonparkmongkol S, Sahakitrungruang T.
Eur J Pediatr; 2017 Apr 18; 176(4):537-545. PubMed ID: 28224294
[Abstract] [Full Text] [Related]
12. Impact of obesity on 24-hour ambulatory blood pressure and hypertension.
Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N.
Hypertension; 2005 Apr 18; 45(4):602-7. PubMed ID: 15723966
[Abstract] [Full Text] [Related]
13. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
Mooij CF, van Herwaarden AE, Sweep FCGJ, Roeleveld N, de Korte CL, Kapusta L, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2017 Aug 28; 30(9):957-966. PubMed ID: 28787274
[Abstract] [Full Text] [Related]
14. Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Subbarayan A, Dattani MT, Peters CJ, Hindmarsh PC.
Clin Endocrinol (Oxf); 2014 Apr 28; 80(4):471-7. PubMed ID: 23751160
[Abstract] [Full Text] [Related]
15. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.
Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP.
J Clin Endocrinol Metab; 2002 May 28; 87(5):2114-20. PubMed ID: 11994350
[Abstract] [Full Text] [Related]
16. Overweight, obesity and elevated blood pressure in children and adolescents.
Schiel R, Beltschikow W, Kramer G, Stein G.
Eur J Med Res; 2006 Mar 27; 11(3):97-101. PubMed ID: 16751109
[Abstract] [Full Text] [Related]
17. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Bonfig W, Schwarz HP.
Clin Endocrinol (Oxf); 2014 Dec 27; 81(6):871-5. PubMed ID: 24818525
[Abstract] [Full Text] [Related]
18. Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.
Mooij CF, Kapusta L, Otten BJ, Claahsen-van der Grinten HL.
Horm Res Paediatr; 2010 Dec 27; 74(5):328-32. PubMed ID: 20357427
[Abstract] [Full Text] [Related]
19. Serum leptin levels in patients with 21-hydroxylase deficiency before and after treatment.
Poyrazoglu S, Günöz H, Darendeliler F.
Turk J Pediatr; 2003 Dec 27; 45(1):33-8. PubMed ID: 12718369
[Abstract] [Full Text] [Related]
20. Circadian blood pressure profiles and ambulatory arterial stiffness index in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in relation to their genotypes.
Janus D, Wójcik M, Tyrawa K, Janeczko M, Bik-Multanowski M, Fijorek K, Drozdz D, Kwiatek K, Starzyk JB.
Neuro Endocrinol Lett; 2017 Dec 27; 38(7):509-518. PubMed ID: 29369603
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
